NL-OMON44455招募中不适用
PRISMA study: Personalised RISk-based MAmmascreening - PRISMA study
Health Evidence0 个研究点目标入组 90,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 90,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Women invited for breast cancer screening
- •- Able to communicate in Dutch
- •- Able to read and understand the participant information and informed consent form
排除标准
- •- Women who cannot make the decision to participate by themselves (mentally ill or mentally handicapped)
- •- Not able to fill out a web-based questionnaire
研究者
相似试验
Unknown
不适用
Healthy Pregnancy 4 All -2: Maternity carePregnancy, patient tailored care, maternity care, antenatal care, maternal empowermentNL-OMON29568The research team has received funding from the Ministry of Health, Welfare and Sports in order to execute the Healthy Pregnancy 4 All study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of a manuscript.1,711
已完成
不适用
PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)Breast CancerNCT02269813West German Study Group452
进行中（未招募）
1 期
Trial investigating a personalized treatment, based on age and tumor characteristics , of newly diagnosed medullablastoma in patients that are postpubertal and/or adult consisting of lowering RT,chemotherapy doses and adding an investigative drug.EUCTR2020-003063-26-FREuropean Organisation for Research and Treatment of205
尚未招募
不适用
Presepsin for sepsis diagnosisCTRI/2018/10/016077All India Institute of Medical Sciences Jodhpur
进行中（未招募）
不适用
The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas PatientsSoft-tissue SarcomaPredictive Cancer ModelNCT05741944Leiden University Medical Center120